Abstract
The last decade has witnessed great progresses regarding the molecular basis of breast cancer with discovery of different nuclear susceptibility genes; in addition investigations and researches regarding mitochondrial DNA (mtDNA) mutations in breast cancer have been started. Mitochondrial haplogroup determinants (single nucleotide polymorphism SNP) and somatic mitochondrial mutations have recently been studied as possible risk factors for carcinogenic processes in different tissues, hence in order to identify breast cancer related SNPs and haplogroups among the population of Sulaimaniyah city/Iraq, the entire mitochondrial genome of 20-breast cancer samples and comparable controls were sequenced. Haplogrep 2.0 was used for haplogroup identification; Chi-square and Fishers exact test were applied to assess relational significance. HV haplogroup in the cancer samples appeared to be a risk factor for breast cancer compared to the most common H haplogroup in control samples with a p-values of 0.002 and 0.006 respectively and an Odd Ratio (OR) = 28.00. Besides, SNP (A8860G) was also identified as a risk factor for breast cancer as compared to other randomly selected SNPs (A750G, A1438G and C7028T) with p values □0.05 and OR >1.
- Breast Cancer
- Mitochondrial DNA
- Haplogroup
- SNP
- Sulaimaniyah City
Competing Interest Statement
funded by university of Sulaimani and kissr (Kurdistan institute for strategic studies and scientific research)
Funding Statement
The study was funded by university of Sulaimani and KISSR (Kurdistan institute for strategic studies and scientific research)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethical Committee of Collage of Medicine/University of Sulaimani (No. 44) on January 30, 2017. List of Full names and Affiliations of the Ethical Committee members: 1.Bakhtiar Mohammed Mahmoud (head of committee) Collage of Medicine - University of Sulaimani 2.Saeed A. lateef A. Kareem (member) Collage of Dentistry - University of Sulaimani 3.Farhad.M.Abdulkarim (member) Kurdistan Institute for Strategic studies and Scientific Research 4.Anwar abubaker Karem (member) Collage of Law - University of Sulaimani 5.Sardar Rasheed Hama Salih (member) Collage of Islamic science - University of Sulaimani 6.Tavga Ahmad Aziz (member) Collage of pharmacy - University of Sulaimani 7.Dyary Hiewa Othman (member) Collage of veterinary - University of Sulaimani 8.Fatah Hama Raheem (member) Collage of Medicine - University of Sulaimani 9.Mohamad Rasheed Ameen (member) Collage of Nursing - University of Sulaimani
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials. More details will be provided by corresponding author upon request
